Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Sep 11;10(1):14949.
doi: 10.1038/s41598-020-71938-3.

Central serous chorioretinopathy and heart rate variability analysis with a smartphone application

Affiliations
Clinical Trial

Central serous chorioretinopathy and heart rate variability analysis with a smartphone application

Keigo Takeshima et al. Sci Rep. .

Abstract

The purpose of this study was to quantitatively analyze heart rate variability (HRV) in patients with central serous chorioretinopathy (CSC) by using a smartphone-based application (ANBAI: DUMSCO Inc.) for measurement, and to clarify its relationships with CSC. The subjects were 64 CSC patients (mean age 48.7 ± 7.6 years, 57 males and 7 females). After providing consent, the patients downloaded ANBAI apps to their smartphones. HRV was measured by photoelectric volume pulse wave measurement with a smartphone camera each morning for a minimum of 1 week. The primary outcome was to analyze HRV by calculating log LF/HF (Low Frequency/High Frequency components), an index of autonomic tone, which was then compared with a control group of 35,226 individuals from the application. Secondary outcome measures included disease duration, body mass index, exercise habits, smoking history, steroid use, occupation, lifestyle regularity, psychological fatigue, physical fatigue, and average sleep time. The log LF/HF was significantly higher in the patient group than in the control group (P < 0.001). Log LF/HF was significantly lower in patients with exercise habits as a factor contributing to log LF/HF in the patient group (P = 0.019). Analysis of HRV in CSC patients showed an impairment of the autonomic nervous system. Exercise habits may also be associated with CSC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Heart rate variability waveform. This figure shows data for heart rate variability time recorded over a 300 s period under resting conditions in a healthy individual. Units on the horizontal axis are times (s) and units on the vertical axis are heart rate intervals (ms).
Figure 2
Figure 2
Power spectral density and spectral components. LF (Low Frequency) is represented by the red area, and HF (High Frequency) by the blue area. To measure the areas of the HF and LF components, the LF component region of the power spectrum (0.05 Hz to 0.15 Hz) and the intensity of the HF component region (0.15 Hz to 0.40 Hz) are combined.
Figure 3
Figure 3
How to measure heart rate variability with a smartphone. The smartphone application (ANBAI: DUMSCO, Inc.) uses the camera (CMOS; complementary metal-oxide semiconductor) attached to the smartphone as a light receptor and the LED (Light Emitting Diode) flashlight as a light source to make the smartphone an optical electric volume pulse wave measuring device, and the data thus obtained can be used to perform heart rate variability analysis.

References

    1. Kim YK, et al. Association of central serous chorioretinopathy with psychosocial factors is dependent on its phase and subtype. Korean J. Ophthalmol. 2018;32:281–289. - PMC - PubMed
    1. Lahousen T, et al. Psychological factors associated with acute and chronic central serous chorioretinopathy. Nord. J. Psychiatry. 2016;70:24–30. - PubMed
    1. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Trans. Am. Ophthalmol. Soc. 1986;84:799–845. - PMC - PubMed
    1. Tsai DC, et al. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A population-based study in Taiwan. Retina. 2014;34:1867–1874. - PubMed
    1. Nicholson BP, Atchison E, Idris AA, Bakri SJ. Central serous chorioretinopathy and glucocorticoids: An update on evidence for association. Surv. Ophthalmol. 2018;63:1–8. - PubMed